<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-133055</identifier>
<setSpec>1699-695X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Monostotic Paget´s Disease</dc:title>
<dc:description xml:lang="en">The present is the case of a patient who was by chance detected a deformity in his upper arm due to Paget´s Disease localized in the humerus. Paget´s Disease is the second most common metabolic disease after osteoporosis, affecting 3% of the population over the age of 55 in Spain. While its etiology remains elusive, genetic factors and viral implications are involved. It can affect one or several bones causing pain, deformities and fractures, especially in long bones. Radiologic tests are the key for correct diagnosis in case of disease suspicion and biochemical resorption bone markers could also be useful. The basic pillar of therapy is based on the use of bisphosphonates (AU)</dc:description>
<dc:creator>Babiano Fernández, Miguel Ángel</dc:creator>
<dc:creator>Rodríguez Fernández, Alfredo</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Presentamos el caso de un paciente al que, de modo casual, se detecta deformidad de miembro superior debido a enfermedad de Paget localizada en húmero. La enfermedad de Paget es la segunda enfermedad ósea metabólica en frecuencia después de la osteoporosis, afectando en España a un 3 % de la población mayor de 55 años. Aunque de causa desconocida, tiene implicaciones genéticas y víricas. Puede afectar a uno o varios huesos produciendo dolor, deformidad y fracturas, sobre todo en huesos largos. La radiología es la clave del diagnóstico en caso de sospecha y los marcadores bioquímicos de reabsorción ósea pueden sernos de utilidad. El pilar básico del tratamiento se basa en el uso de bifosfonatos (AU)</dc:description>
<dc:source>Rev. clín. med. fam;7(3): 227-230, oct. 2014. ilus</dc:source>
<dc:identifier>ibc-133055</dc:identifier>
<dc:title xml:lang="es">Enfermedad de Paget monostótica</dc:title>
<dc:subject>^d24737^s22012</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d36500^s22053</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:subject>^d10177^s29166</dc:subject>
<dc:subject>^d32289^s22058</dc:subject>
<dc:subject>^d6963^s22053</dc:subject>
<dc:subject>^d10177^s22012</dc:subject>
<dc:subject>^d36500^s22058</dc:subject>
<dc:subject>^d24737^s29166</dc:subject>
<dc:subject>^d32289^s22053</dc:subject>
<dc:subject>^d10177^s22016</dc:subject>
<dc:subject>^d23568</dc:subject>
<dc:subject>^d1887^s22016</dc:subject>
<dc:subject>^d6963^s22058</dc:subject>
<dc:type>article</dc:type>
<dc:date>201410</dc:date>
</metadata>
</record>
</ibecs-document>
